Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
47
CURI Quote, Financials, Valuation and Earnings
Last price:
$4.45
Seasonality move
:
-3.83%
Day range:
$4.28 - $4.50
52-week range:
$0.99 - $7.15
Dividend yield:
3.94%
P/E ratio:
--
P/S ratio:
4.42x
P/B ratio:
4.27x
Volume:
314.6K
Avg. volume:
847.1K
1-year change:
269.23%
Market cap:
$248M
Revenue:
$51.1M
EPS (TTM):
-$0.14
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $39.6M | $71.3M | $78M | $56.9M | $51.1M | |
| Revenue Growth (YoY) | 119.8% | 79.86% | 9.52% | -27.11% | -10.12% | |
| Cost of Revenues | $15.4M | $36.7M | $51.5M | $35.6M | $25.4M | |
| Gross Profit | $24.2M | $34.6M | $26.5M | $21.3M | $25.8M | |
| Gross Profit Margin | 61.09% | 48.54% | 33.97% | 37.51% | 50.4% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $63M | $87.1M | $78.2M | $46.8M | $39.1M | |
| Other Inc / (Exp) | -$10.1M | $14.7M | $955K | -$24.2M | -$2.6M | |
| Operating Expenses | $63M | $87.1M | $78.2M | $46.8M | $39.1M | |
| Operating Income | -$38.8M | -$52.5M | -$51.7M | -$25.5M | -$13.3M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$48.4M | -$37.3M | -$50.6M | -$48.4M | -$12.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $179K | $360K | $367K | $506K | $132K | |
| Net Income to Company | -$48.6M | -$37.6M | -$50.9M | -$48.9M | -$12.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$48.6M | -$37.6M | -$50.9M | -$48.9M | -$12.9M | |
| Basic EPS (Cont. Ops) | -$3.30 | -$0.73 | -$0.96 | -$0.92 | -$0.24 | |
| Diluted EPS (Cont. Ops) | -$3.30 | -$1.02 | -$0.96 | -$0.92 | -$0.24 | |
| Weighted Average Basic Share | $18.9M | $51.5M | $52.8M | $53M | $54.5M | |
| Weighted Average Diluted Share | $18.9M | $51.8M | $52.8M | $53M | $54.5M | |
| EBITDA | -$28.7M | -$24M | -$11.7M | -$2.1M | $6.1M | |
| EBIT | -$38.8M | -$52.5M | -$51.7M | -$25.5M | -$13.3M | |
| Revenue (Reported) | $39.6M | $71.3M | $78M | $56.9M | $51.1M | |
| Operating Income (Reported) | -$38.8M | -$52.5M | -$51.7M | -$25.5M | -$13.3M | |
| Operating Income (Adjusted) | -$38.8M | -$52.5M | -$51.7M | -$25.5M | -$13.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $9.9M | $17.6M | $12.4M | $12M | $15.1M | |
| Revenue Growth (YoY) | 33.07% | 77.41% | -29.73% | -3.12% | 25.74% | |
| Cost of Revenues | $4.2M | $11.9M | $9M | $6.7M | $7.1M | |
| Gross Profit | $5.8M | $5.8M | $3.4M | $5.3M | $8M | |
| Gross Profit Margin | 58.15% | 32.77% | 27.34% | 43.77% | 53.08% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $21M | $25.3M | $11.2M | $8.9M | $7.9M | |
| Other Inc / (Exp) | -$3.8M | $3.7M | -$293K | -$1.8M | -$158K | |
| Operating Expenses | $21M | $25.3M | $11.2M | $8.9M | $7.9M | |
| Operating Income | -$15.2M | -$19.5M | -$7.8M | -$3.7M | $79K | |
| Net Interest Expenses | -- | $57K | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$18.7M | -$15.8M | -$7.7M | -$5M | $347K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $26K | $45K | $58K | $34K | $28K | |
| Net Income to Company | -$18.8M | -$15.9M | -$7.8M | -$5M | $319K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$18.8M | -$15.9M | -$7.8M | -$5M | $319K | |
| Basic EPS (Cont. Ops) | -$0.39 | -$0.30 | -$0.15 | -$0.09 | $0.01 | |
| Diluted EPS (Cont. Ops) | -$0.39 | -$0.30 | -$0.15 | -$0.09 | $0.01 | |
| Weighted Average Basic Share | $48.1M | $52.8M | $53M | $53.3M | $57.1M | |
| Weighted Average Diluted Share | $48.1M | $52.8M | $53M | $53.3M | $57.1M | |
| EBITDA | -$12.4M | -$10.2M | -$1.8M | $1.7M | $3.6M | |
| EBIT | -$15.2M | -$19.5M | -$7.8M | -$3.7M | $79K | |
| Revenue (Reported) | $9.9M | $17.6M | $12.4M | $12M | $15.1M | |
| Operating Income (Reported) | -$15.2M | -$19.5M | -$7.8M | -$3.7M | $79K | |
| Operating Income (Adjusted) | -$15.2M | -$19.5M | -$7.8M | -$3.7M | $79K | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $42.1M | $79M | $72.8M | $56.5M | $54.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $16.9M | $44.4M | $48.7M | $33.3M | $25.7M | |
| Gross Profit | $25.2M | $34.6M | $24.1M | $23.2M | $28.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $67.1M | $91.4M | $64.1M | $44.6M | $38.1M | |
| Other Inc / (Exp) | -$3.8M | $22.2M | -$3M | -$25.7M | -$922K | |
| Operating Expenses | $67.1M | $91.4M | $64.1M | $44.6M | $38.1M | |
| Operating Income | -$41.9M | -$56.8M | -$40M | -$21.4M | -$9.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$55.4M | -$34.4M | -$42.4M | -$45.7M | -$7.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $168K | $379K | $380K | $482K | $126K | |
| Net Income to Company | -$55.6M | -$34.8M | -$42.8M | -$46.2M | -$7.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$55.6M | -$34.8M | -$42.8M | -$46.2M | -$7.6M | |
| Basic EPS (Cont. Ops) | -$2.57 | -$0.66 | -$0.82 | -$0.87 | -$0.14 | |
| Diluted EPS (Cont. Ops) | -$2.57 | -$0.85 | -$0.82 | -$0.87 | -$0.14 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$30.6M | -$21.9M | -$3.3M | $1.4M | $8.1M | |
| EBIT | -$41.9M | -$56.8M | -$40M | -$21.4M | -$9.6M | |
| Revenue (Reported) | $42.1M | $79M | $72.8M | $56.5M | $54.2M | |
| Operating Income (Reported) | -$41.9M | -$56.8M | -$40M | -$21.4M | -$9.6M | |
| Operating Income (Adjusted) | -$41.9M | -$56.8M | -$40M | -$21.4M | -$9.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $9.9M | $17.6M | $12.4M | $12M | $15.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $4.2M | $11.9M | $9M | $6.7M | $7.1M | |
| Gross Profit | $5.8M | $5.8M | $3.4M | $5.3M | $8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $21M | $25.3M | $11.2M | $8.9M | $7.9M | |
| Other Inc / (Exp) | -$3.8M | $3.7M | -$293K | -$1.8M | -$158K | |
| Operating Expenses | $21M | $25.3M | $11.2M | $8.9M | $7.9M | |
| Operating Income | -$15.2M | -$19.5M | -$7.8M | -$3.7M | $79K | |
| Net Interest Expenses | -- | $57K | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$18.7M | -$15.8M | -$7.7M | -$5M | $347K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $26K | $45K | $58K | $34K | $28K | |
| Net Income to Company | -$18.8M | -$15.9M | -$7.8M | -$5M | $319K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$18.8M | -$15.9M | -$7.8M | -$5M | $319K | |
| Basic EPS (Cont. Ops) | -$0.39 | -$0.30 | -$0.15 | -$0.09 | $0.01 | |
| Diluted EPS (Cont. Ops) | -$0.39 | -$0.30 | -$0.15 | -$0.09 | $0.01 | |
| Weighted Average Basic Share | $48.1M | $52.8M | $53M | $53.3M | $57.1M | |
| Weighted Average Diluted Share | $48.1M | $52.8M | $53M | $53.3M | $57.1M | |
| EBITDA | -$12.4M | -$10.2M | -$1.8M | $1.7M | $3.6M | |
| EBIT | -$15.2M | -$19.5M | -$7.8M | -$3.7M | $79K | |
| Revenue (Reported) | $9.9M | $17.6M | $12.4M | $12M | $15.1M | |
| Operating Income (Reported) | -$15.2M | -$19.5M | -$7.8M | -$3.7M | $79K | |
| Operating Income (Adjusted) | -$15.2M | -$19.5M | -$7.8M | -$3.7M | $79K | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $11.2M | $15.2M | $40M | $37.7M | $7.8M | |
| Short Term Investments | $22.2M | $65.8M | $15M | -- | $24.2M | |
| Accounts Receivable, Net | $7.2M | $23.5M | $10.9M | $4.8M | $6.1M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $4.5M | $6.4M | $3.1M | $2.3M | $1.2M | |
| Total Current Assets | $51.2M | $113.3M | $69.5M | $45.3M | $39.5M | |
| Property Plant And Equipment | $1.3M | $1.2M | $4.8M | $4.1M | $3.6M | |
| Long-Term Investments | $2.8M | $25.4M | $10.8M | $6.4M | $11.3M | |
| Goodwill | -- | $2.8M | -- | -- | -- | |
| Other Intangibles | $32.9M | $74.2M | $68.5M | $44.9M | $31.5M | |
| Other Long-Term Assets | $254K | $689K | $539K | $358K | $257K | |
| Total Assets | $88.6M | $217.6M | $154.1M | $101M | $86.2M | |
| Accounts Payable | $3.6M | $3.4M | $6.1M | $4.8M | $5.6M | |
| Accrued Expenses | $3.3M | $12.4M | $7.8M | $1.3M | $2.5M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | $365K | $396K | |
| Other Current Liabilities | $2.1M | $9.7M | $2.9M | $1.4M | $2M | |
| Total Current Liabilities | $21.7M | $48M | $31M | $23.4M | $23.9M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $43.6M | $55.6M | $36.5M | $28.4M | $28.3M | |
| Common Stock | $4K | $5K | $5K | $5K | $5K | |
| Other Common Equity Adj | $10K | -$222K | -$40K | -- | -- | |
| Common Equity | $45M | $161.9M | $117.6M | $72.6M | $57.8M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $45M | $161.9M | $117.6M | $72.6M | $57.8M | |
| Total Liabilities and Equity | $88.6M | $217.6M | $154.1M | $101M | $86.2M | |
| Cash and Short Terms | $33.4M | $81M | $55M | $37.7M | $32.1M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $11.8M | $22.7M | $48.7M | $38.8M | $9.2M | |
| Short Term Investments | $84.7M | $60M | -- | -- | $24.3M | |
| Accounts Receivable, Net | $7M | $13.4M | $9.7M | $4.9M | $7.7M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $5.2M | $4.2M | $2.2M | $1.8M | $1.2M | |
| Total Current Assets | $114.8M | $102.5M | $61.1M | $45.6M | $42.5M | |
| Property Plant And Equipment | $1.3M | $5.2M | $4.6M | $3.9M | $3.5M | |
| Long-Term Investments | $75.4M | $10.6M | $10.5M | $4.6M | $9.2M | |
| Goodwill | -- | $2.8M | -- | -- | -- | |
| Other Intangibles | $39.2M | $79.4M | $66.4M | $40.2M | $29.8M | |
| Other Long-Term Assets | $267K | $686K | $493K | $311K | $244K | |
| Total Assets | $230.9M | $201.2M | $143.1M | $94.6M | $85.3M | |
| Accounts Payable | $6.1M | $8.4M | $7.5M | $3.3M | $4.8M | |
| Accrued Expenses | $2.3M | $9.2M | $3.4M | $4.8M | $3.4M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | $404K | |
| Other Current Liabilities | $3.5M | $4M | $1.7M | $74K | $2.8M | |
| Total Current Liabilities | $28.7M | $46.3M | $26.4M | $22.8M | $22.8M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $54.7M | $53.7M | $31.9M | $27.6M | $27.1M | |
| Common Stock | $5K | $5K | $5K | $5K | $5K | |
| Other Common Equity Adj | -$444K | -$455K | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $176.2M | $147.5M | $111.2M | $67M | $58.1M | |
| Total Liabilities and Equity | $230.9M | $201.2M | $143.1M | $94.6M | $85.3M | |
| Cash and Short Terms | $96.5M | $82.7M | $48.7M | $38.8M | $33.4M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$48.6M | -$37.6M | -$50.9M | -$48.9M | -$12.9M | |
| Depreciation & Amoritzation | $10.1M | $28.5M | $40M | $23.4M | $19.5M | |
| Stock-Based Compensation | $4.3M | $7M | $6.6M | $4M | $6.6M | |
| Change in Accounts Receivable | -$5.4M | -$16.2M | $11.9M | $6.1M | -$1.3M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$53.5M | -$73.2M | -$39.5M | -$16.2M | $8.2M | |
| Capital Expenditures | $367K | $351K | $130K | $5K | -- | |
| Cash Acquisitions | -- | -$15M | -$2.4M | -$992K | -- | |
| Cash From Investing | $25.5M | -$74.9M | $62.7M | $14M | -$31.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$4.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $9.8M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$9.8M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$251K | |
| Other Financing Activities | $36.4M | -$1.2M | -$218K | -$123K | -$2.7M | |
| Cash From Financing | $36.6M | $148.3M | -$218K | -$123K | -$7M | |
| Beginning Cash (CF) | $8.8M | $17.4M | $17.5M | $40.5M | $38.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $8.6M | $163K | $23M | -$2.3M | -$30.3M | |
| Ending Cash (CF) | $17.4M | $17.5M | $40.5M | $38.2M | $8M | |
| Levered Free Cash Flow | -$53.9M | -$73.6M | -$39.7M | -$16.2M | $8.2M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$8.3M | -$16M | -$9.9M | -$2M | -- | |
| Depreciation & Amoritzation | $4.4M | $10.3M | $6.6M | $4.8M | -- | |
| Stock-Based Compensation | $1.5M | $1.6M | $1.4M | $1.3M | -- | |
| Change in Accounts Receivable | -$3.8M | $1.8M | $612K | $270K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$10.8M | -$5.9M | -$4.3M | $2.2M | -- | |
| Capital Expenditures | $175K | $98K | -- | -- | -- | |
| Cash Acquisitions | -$4M | -$812K | -- | -- | -- | |
| Cash From Investing | $6.7M | $4.3M | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$1.3M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | $100K | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -$26K | -- | |
| Other Financing Activities | -$316K | -$24K | -$31K | -$62K | -- | |
| Cash From Financing | -$200K | -$24K | -$31K | -$1.4M | -- | |
| Beginning Cash (CF) | $18M | $24.9M | $49.2M | $38.9M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$4.3M | -$1.6M | -$4.3M | $769K | -- | |
| Ending Cash (CF) | $13.8M | $23.3M | $44.8M | $39.6M | -- | |
| Levered Free Cash Flow | -$10.9M | -$6M | -$4.3M | $2.2M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$55.6M | -$34.8M | -$42.8M | -$46.2M | -$7.6M | |
| Depreciation & Amoritzation | $11.3M | $34.9M | $36.7M | $22.8M | $17.7M | |
| Stock-Based Compensation | $6.3M | $6.4M | $6.1M | $3.4M | $6.7M | |
| Change in Accounts Receivable | -$4.4M | -$6.5M | $3M | $4.8M | -$2.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$43.8M | -$72.9M | -$33.5M | -$9.2M | $9.4M | |
| Capital Expenditures | $173K | $373K | $113K | -- | $77K | |
| Cash Acquisitions | -- | -$15.8M | -$1.6M | -$992K | -- | |
| Cash From Investing | -$135.7M | $80.5M | $57.9M | -$992K | -$29.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$6.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$885K | -$107K | -$103K | -$3M | |
| Cash From Financing | $184.5M | -$676K | -$107K | -$103K | -$9.6M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $5M | $6.9M | $24.3M | -$10.3M | -$29.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$44M | -$73.3M | -$33.7M | -$9.2M | $9.3M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$27.1M | -$31.9M | -$17.7M | -$7.1M | $319K | |
| Depreciation & Amoritzation | $7.2M | $19.6M | $12.6M | $10.1M | $3.6M | |
| Stock-Based Compensation | $3.9M | $3.4M | $2.7M | $2M | $863K | |
| Change in Accounts Receivable | -$3.5M | $11.9M | $1.8M | $154K | -$1.6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$23.4M | -$18.1M | -$10.6M | $2.9M | $1.9M | |
| Capital Expenditures | $175K | $120K | $5K | -- | $77K | |
| Cash Acquisitions | -$4M | -$1.6M | -- | -- | -- | |
| Cash From Investing | -$129M | $24M | $15M | -- | $2.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$1.3M | -$2.3M | |
| Special Dividend Paid | -- | -- | -- | -- | $100K | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -$26K | -- | |
| Other Financing Activities | -$729K | -$161K | -$57K | -$68K | -$358K | |
| Cash From Financing | $148.7M | -$161K | -$57K | -$1.4M | -$2.6M | |
| Beginning Cash (CF) | $35.4M | $42.4M | $89.7M | $77.1M | $8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$3.6M | $5.7M | $4.3M | $1.4M | $1.4M | |
| Ending Cash (CF) | $31.8M | $48.2M | $94M | $78.5M | $9.3M | |
| Levered Free Cash Flow | -$23.5M | -$18.3M | -$10.6M | $2.9M | $1.8M | |
Get CURI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CURI
Sector
P/E ratio
--
17.70x
PEG ratio
-1.52x
0.00x
P/B ratio
4.27x
1.49x
Price / LTM sales
4.42x
0.96x
Growth Metrics
CURI
Sector
Revenue growth
25.74%
-0.53%
Earnings growth
--
-0.61%
Revenue (5-year growth)
23.19%
1.59%
Earnings forecast
$0.01
$0.05
Profitability
CURI
Sector
Profitability FY 2024
$25.8M
$256.3M
Return on invested capital
-12.24%
0.79%
Return on assets
-8.54%
0.12%
Return on equity
-12.24%
2.1%
Earnings Date
Last Earnings Date
May
6
Next Earnings Date
Aug
13
Estimated Next Earnings Date
Aug
5
Balance Sheet
CURI
Sector
Total cash
$33.4M
$97.1M
Short term investments
$24.2M
$26.8M
Total assets
$86.2M
$827.5M
Long term debt
--
$44M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
